Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
ADHD Capsules Recalled
10/29/2020
ANI Pharmaceuticals Inc. is voluntarily recalling dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules.
ANI Pharmaceuticals Inc. is voluntarily recalling dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release capsules.
ANI Pharmaceuticals Inc. is...
10/29/2020
Pharmacy Learning Network

Advertisement

News
Blood Pressure Drug Recalled
10/29/2020
A prescription angiotensin II receptor blocker used to treat high blood pressure and heart failure is being recalled.
A prescription angiotensin II receptor blocker used to treat high blood pressure and heart failure is being recalled.
A prescription angiotensin II...
10/29/2020
Pharmacy Learning Network
News
Subpotent Thyroid Tablets Under Class I Recall
10/29/2020
A Class I recall has been issued for two lots of NP Thyroid tablets because of subpotency.
A Class I recall has been issued for two lots of NP Thyroid tablets because of subpotency.
A Class I recall has been issued...
10/29/2020
Pharmacy Learning Network
News
Scientists Warn Americans Are Expecting Too Much From a Vaccine
10/28/2020
Some argue that vaccines capable of preventing any COVID-19 symptoms should qualify for widespread use, but others want much larger trials to prove that vaccines can reduce hospitalizations or deaths.
Some argue that vaccines capable of preventing any COVID-19 symptoms should qualify for widespread use, but others want much larger trials to prove that vaccines can reduce hospitalizations or deaths.
Some argue that vaccines capable...
10/28/2020
Pharmacy Learning Network

Advertisement

News
Weighing the Pros and Cons of Telemedicine Versus In-Person Visits
10/27/2020
The volume of virtual medical appointments has exploded during the pandemic as patients and doctors have sought to avoid infection through in-person visits.
The volume of virtual medical appointments has exploded during the pandemic as patients and doctors have sought to avoid infection through in-person visits.
The volume of virtual medical...
10/27/2020
Pharmacy Learning Network
News
No Bidders for Canada Drug Importation Program in Florida
10/26/2020
After bids were due at the end of September, there were no private firms that bid on Florida’s $30 million contract to set up and operate a drug importation program, which will likely delay the states efforts to become the first state to...
After bids were due at the end of September, there were no private firms that bid on Florida’s $30 million contract to set up and operate a drug importation program, which will likely delay the states efforts to become the first state to...
After bids were due at the end...
10/26/2020
Pharmacy Learning Network
News
Pharmacist-Driven MRSA Nasal Screening Reduces Duration of Parenteral Vancomycin
10/23/2020
A pharmacist-driven protocol for MRSA nasal swab PCR screening reduced the duration of parenteral vancomycin therapy in patients with lower respiratory tract infection.
A pharmacist-driven protocol for MRSA nasal swab PCR screening reduced the duration of parenteral vancomycin therapy in patients with lower respiratory tract infection.
A pharmacist-driven protocol for...
10/23/2020
Pharmacy Learning Network

Advertisement

News
Eye Solution Recalled
10/23/2020
A recall is active for a prescription eye solution used to treat corneal crystals in patients with cystinosis.
A recall is active for a prescription eye solution used to treat corneal crystals in patients with cystinosis.
A recall is active for a...
10/23/2020
Pharmacy Learning Network
News
Appetite Suppressant Recalled
10/16/2020
A Class II recall is active for a prescription stimulant that is used as an appetite suppressant to treat obesity.
A Class II recall is active for a prescription stimulant that is used as an appetite suppressant to treat obesity.
A Class II recall is active for...
10/16/2020
Pharmacy Learning Network
News
Antifungal Recalled
10/16/2020
A recall is ongoing for a prescription medicine indicated for the treatment of candidiasis in the mouth.
A recall is ongoing for a prescription medicine indicated for the treatment of candidiasis in the mouth.
A recall is ongoing for a...
10/16/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use